FTC's Campaign Against Improper Orange Book Listings Continues With Amicus Brief In Teva's Challenge Of Amneal Asthma Inhaler ANDA - Antitrust, EU Competition
The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency's...
Source: mondaq.com